Skip to main content

Table 2 Validation of Apo-A1 as biomarker for diagnosis (A) and classification (B) of BTCC

From: Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma

A
Gold standard Apo-A1 expression
  >18.22 ng/ml <18.22 ng/ml
BTCC (107) 98 9
Benign damage (49) 7 42
B
Gold standard Apo-A1 expression
  >29.86 ng/ml <29.86 ng/ml
Aggressive BTCC (49) 41 8
Low Malignant BTCC (58) 6 52